Not currently recruiting at UCLA
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Santa Monica 5393212, California 5332921 and other locations
- Dates
- study startedstudy ends around
- Principal Investigator
- by Zev A. Wainberg, MD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Zev A. Wainberg, MD
Zev Wainberg, M.D., holds the Estelle, Abe, and Marjorie Sanders Chair in Cancer Research.
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Links
- Sign up for this study
- ID
- NCT06859762
- Phase
- Phase 1 Solid Tumor Research Study
- Study Type
- Interventional
- Participants
- Expecting 220 study participants
- Last Updated